164 related articles for article (PubMed ID: 25598955)
1. The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer.
Hiradfar A; Banihosseinian M
Iran J Ped Hematol Oncol; 2014; 4(4):151-9. PubMed ID: 25598955
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
5. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Abdelrazik N; Fouda M
Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
[TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study).
Wurnig C; Windhager R; Schwameis E; Kotz R; Zoubek A; Stockenhuber F; Kurz RW
Transfusion; 1996 Feb; 36(2):155-9. PubMed ID: 8614967
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
11. Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.
Mirtsching B; Charu V; Vadhan-Raj S; Colowick AB; Rossi G; Tomita D; McGuire WP
Oncology (Williston Park); 2002 Oct; 16(10 Suppl 11):31-6. PubMed ID: 12435171
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant erythropoietin in autologous blood donation].
von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin reduces allogeneic blood transfusion requirements in patients undergoing major orthopedic surgery.
Tamir L; Fradin Z; Fridlander M; Ashkenazi U; Zeidman A; Cohen AM; Hendel D; Mittelman M
Haematologia (Budap); 2000; 30(3):193-201. PubMed ID: 11128112
[TBL] [Abstract][Full Text] [Related]
14. A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
Glaspy JA; Jadeja JS; Justice G; Fleishman A; Rossi G; Colowick AB
Cancer; 2003 Mar; 97(5):1312-20. PubMed ID: 12599240
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
[TBL] [Abstract][Full Text] [Related]
16. The effects of recombinant human erythropoietin on autologous blood donation in rheumatoid arthritis patients with anaemia.
Matsui H; Shiraishi N; Yasuda T; Nezuka T
Clin Exp Rheumatol; 1999; 17(1):69-74. PubMed ID: 10084035
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.
Kurz Ch; Marth Ch; Windbichler G; Lahousen M; Medl M; Vavra N; Sevelda P
Gynecol Oncol; 1997 Jun; 65(3):461-6. PubMed ID: 9190976
[TBL] [Abstract][Full Text] [Related]
19. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
Voils SA; Harpe SH; Brophy GM
Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
[TBL] [Abstract][Full Text] [Related]
20. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
